Suppr超能文献

监管失败导致活体肾脏捐献者死亡。

Regulatory failure contributing to deaths of live kidney donors.

机构信息

Department of Surgery, Division of Transplantation, SUNY Upstate Medical University, Syracuse, NY, USA.

出版信息

Am J Transplant. 2012 Apr;12(4):829-34. doi: 10.1111/j.1600-6143.2011.03918.x. Epub 2012 Jan 10.

Abstract

Hemorrhagic deaths of living kidney donors from failure of vascular clips used on the renal artery, first documented in 2006, have continued due to postoperative Hem-o-lok clip failure with sudden, massive bleeding. While the FDA issued a Class II recall of the Hem-o-lok clip for laparoscopic donor nephrectomies in 2006, two live kidney donors in the United States and one in India have since died. Compliance in timely reporting of deaths by the manufacturer and donor hospitals has not been enforced. Oversight agencies did not inform practitioners that donors died due to clip failures. A February 2011 survey disclosed that Hem-o-lok or other clips are still used by some surgeons as a sole means of arterial control in laparoscopic donor nephrectomy; thus, a practice with documented fatal outcomes persists. We conclude that systems failures by oversight-regulatory agencies in communication to active clinicians led, at least in part, to preventable deaths. Information which was disseminated was neither complete nor timely. A corrective plan, funded by oversight agencies and the Hem-o-lok manufacturer, is proposed. All surgeons operating on a living organ donor must select vascular control techniques that entail tissue transfixion and assure a safe operative recovery. The Hem-o-lok and other surgical clips must not be used to control the donor renal artery.

摘要

2006 年首次记录到因用于肾动脉的血管夹失效导致活体供肾者出血性死亡,此后由于术后 Hem-o-lok 夹失效导致突然大量出血,此类死亡事件仍在继续。尽管美国食品药品监督管理局 (FDA) 于 2006 年对腹腔镜供肾切取术的 Hem-o-lok 夹发出了 II 级召回通知,但此后在美国和印度各有 1 名活体供肾者死亡。制造商和供肾医院及时报告死亡事件的合规性并未得到执行。监督机构没有告知医生供者因夹失效而死亡。2011 年 2 月的一项调查显示,Hem-o-lok 夹或其他夹仍被一些外科医生用作腹腔镜供肾切取术中动脉控制的唯一手段;因此,一种有记录的致命后果的做法仍在继续。我们的结论是,监督管理机构在向活跃的临床医生传达信息方面的系统故障至少在一定程度上导致了可预防的死亡。传播的信息既不完整也不及时。我们提出了一项由监督机构和 Hem-o-lok 制造商资助的纠正计划。所有对活体器官供者进行手术的外科医生必须选择需要组织贯穿并确保安全手术恢复的血管控制技术。Hem-o-lok 夹和其他手术夹不得用于控制供肾动脉。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验